Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trialTakehito Shukuya, Kazuhisa Takahashi, Yasushi Goto et al.|The Lancet Oncology|2025Cited by 20